Cite

HARVARD Citation

    Pugliese, N. et al. (n.d.). Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic Hepatitis C aged 75 years or older: A multicenter study. Digestive and liver disease. pp. S26-. [Online]. 
  
Back to record